* 7 years from the first and 0 days from the second LT.
Table 2. Patients’ basal characteristics and nebulized
voriconazole treatment description (CF: cystic fibrosis, LT: lung
transplantation, NT: no transplantation, d: days, w: weeks, m: months,
y: years, R: resistant, S: susceptible, DOT: days of treatment, ICU:
intensive care unit, P-ICU: pediatric intensive care unit, neb:
nebulized, IV: intravenous, IP: intrapleural).